HUP2000144A1 - Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása - Google Patents

Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása

Info

Publication number
HUP2000144A1
HUP2000144A1 HU2000144A HUP2000144A HUP2000144A1 HU P2000144 A1 HUP2000144 A1 HU P2000144A1 HU 2000144 A HU2000144 A HU 2000144A HU P2000144 A HUP2000144 A HU P2000144A HU P2000144 A1 HUP2000144 A1 HU P2000144A1
Authority
HU
Hungary
Prior art keywords
bps
medicinal
formulation
pharmaceutical composition
pain syndrome
Prior art date
Application number
HU2000144A
Other languages
English (en)
Inventor
Lovasz Sandor Dr
Original Assignee
Lovasz Sandor Dr
Dr Birinyi Peter
Renyi Gabor
Giber Janos
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lovasz Sandor Dr, Dr Birinyi Peter, Renyi Gabor, Giber Janos filed Critical Lovasz Sandor Dr
Priority to HU2000144A priority Critical patent/HUP2000144A1/hu
Priority to EP21742476.1A priority patent/EP4142700A1/en
Priority to PCT/HU2021/000004 priority patent/WO2021220022A1/en
Priority to US17/922,221 priority patent/US20230165822A1/en
Publication of HUP2000144A1 publication Critical patent/HUP2000144A1/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/194Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HU2000144A 2020-04-29 2020-04-29 Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása HUP2000144A1 (hu)

Priority Applications (4)

Application Number Priority Date Filing Date Title
HU2000144A HUP2000144A1 (hu) 2020-04-29 2020-04-29 Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása
EP21742476.1A EP4142700A1 (en) 2020-04-29 2021-04-29 Urinary alkalizing medicinal and/or pharmaceutical composition for the oral treatment of interstitial cystitis / bladder pain syndrome (ic/bps) and formulation thereof
PCT/HU2021/000004 WO2021220022A1 (en) 2020-04-29 2021-04-29 Urinary alkalizing medicinal and/or pharmaceutical composition for the oral treatment of interstitial cystitis / bladder pain syndrome (ic/bps) and formulation thereof
US17/922,221 US20230165822A1 (en) 2020-04-29 2021-04-29 Urinary alkalizing medicinal and/or pharmaceutical composition for the oral treatment of interstitial cystitis / bladder pain syndrome (ic/bps) and formulation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU2000144A HUP2000144A1 (hu) 2020-04-29 2020-04-29 Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása

Publications (1)

Publication Number Publication Date
HUP2000144A1 true HUP2000144A1 (hu) 2022-04-28

Family

ID=89993112

Family Applications (1)

Application Number Title Priority Date Filing Date
HU2000144A HUP2000144A1 (hu) 2020-04-29 2020-04-29 Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása

Country Status (4)

Country Link
US (1) US20230165822A1 (hu)
EP (1) EP4142700A1 (hu)
HU (1) HUP2000144A1 (hu)
WO (1) WO2021220022A1 (hu)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2493626T3 (es) * 2004-01-28 2014-09-12 The Regents Of The University Of California Nueva terapia intersticial para un alivio inmediato de los síntomas y terapia crónica en la cistitis intersticial
JP2006045200A (ja) * 2004-06-28 2006-02-16 Toru Araki 間質性膀胱炎の治療薬
CN106038523B (zh) * 2016-06-30 2019-11-12 安徽恒星制药有限公司 一种枸橼酸钾枸橼酸钠片及其制备方法

Also Published As

Publication number Publication date
US20230165822A1 (en) 2023-06-01
EP4142700A1 (en) 2023-03-08
WO2021220022A1 (en) 2021-11-04

Similar Documents

Publication Publication Date Title
MX2020008258A (es) Formulaciones pediátricas de niraparib y métodos de tratamiento pediátricos.
EP4110325A4 (en) TRANSDERMAL AND/OR TOPICAL PHARMACEUTICAL FORMULATIONS CONTAINING CANNABIDIOL AND/OR TETRAHYDROCANNABINOL FOR THE TREATMENT OF CHRONIC PAIN
EP1558220A4 (en) ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES
WO2015074045A3 (en) Therapeutic delivery catheter with imaging and tissue characterization
EP2392363A3 (en) Drug coated expandable devices
MX2023010328A (es) Composiciones de medicamentos a base de peptido de colageno y metodos y dispositivos para su produccion y uso.
MX2023000398A (es) Analogos de insulina novedosos y usos de estos.
MX2009012054A (es) Metodos de tratamiento que usan formulaciones intravenosas que comprenden temozolomida.
HUP2000144A1 (hu) Vizelet lúgosító gyógyászati és/vagy gyógyszerkészítmény interstitialis cystitis / hólyagfájdalom szindróma (IC/BPS)orális kezelésére és formulálása
IL299845A (en) Oral unit dose compounds consisting of ibuprofen and famotidine for the treatment of acute pain and to reduce the severity and/or risk of heartburn
EP3909576A4 (en) USE OF CHLOROGENIC ACID IN THE PREPARATION OF A MEDICINE OR A PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF PAIN
IL280550A (en) A pharmaceutical preparation for the safe and effective treatment of pain in the knee and/or hip
EP3818981C0 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION OF THE ACTIVE ENANTIOMER (S)-KETOROLAC AND GABAPENTIN FOR THE TREATMENT OF NEUROPATHIC PAIN
EP3737381A4 (en) MEDICAL DEVICE AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF AN EYE DISEASE OR DISEASE
IL281513A (en) Preparations for the treatment of joint pain
EP3996655A4 (en) MEDICAL DEVICES FOR TREATING DENTAL DISEASES AND METHODS FOR TREATING DENTAL DISEASES
Telang Body art: intraoral tattoos
EP3856148A4 (en) PHARMACEUTICAL FORMULATION CONTAINING A TRIGLYCERIDE SELENITE AND A CYTOSTATIC AGENT FOR USE IN THE TREATMENT OF A TUMOR
EP3838270A4 (en) SYNERGISTIC PHARMACEUTICAL COMPOSITION WITH ACECLOFENAC AND BETAMETHASONE FOR THE TREATMENT OF PAIN IN LOCALIZED FORMS OF RHEUMATIC DISEASES
Ko et al. Comparison of plate versus threaded k-wire for fixation of midshaft clavicular fractures
PH12020551311A1 (en) Treatment of allergic rhinitis in pediatric subjects using a combination of mometasone and olopatadine
EP4084783A4 (en) PHARMACEUTICAL SOLUTION THAT FACILITATES DENTAL REMINERALIZATION AND ELIMINATES LESION PAIN
PL4051249T4 (pl) Kompozycja farmaceutyczna zawierająca mitotan do podawania doustnego do leczenia raka kory nadnerczy oraz zespołu Cushing’a
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
GB2574944A (en) Methods and compositions for the treatment of pain and/or inflammation

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): SOMFAI ES TARSAI IPARJOGI KFT., HU

Representative=s name: JGM OKTATASI ES IPARJOGI KFT., HU

FH92 Termination of representative

Representative=s name: SOMFAI ES TARSAI IPARJOGI KFT., HU

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished